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The fast and intense proliferative responses have been well documented for naïve
T cells adoptively transferred into chronic lymphopenic hosts. This response known
as spontaneous proliferation (SP), unlike antigen-independent lymphopenia-induced
proliferation (LIP), is driven in a manner dependent on antigens derived from commensal
microbiota. However, the precise nature of the SP response and its impact on
homeostasis and function for T cells rapidly responding under this lymphopenic condition
are still unclear. Here we demonstrate that, when naïve T cells were adoptively transferred
into specific pathogen-free (SPF) but not germ-free (GF) RAG−/− hosts, the SP response
of these cells substantially affects the intensity and tempo of the responding T cells
undergoing LIP. Therefore, the resulting response of these cells in SPF RAG−/− hosts
was faster and stronger than the typical LIP response observed in irradiated B6 hosts.
Although the intensity and tempo of such augmented LIP in SPF RAG−/− hosts were
analogous to those of antigen-dependent SP, the former was independent of antigenic
stimulation but most importantly, dependent on IL-2. Similar observations were also
apparent in other acute lymphopenic settings where antigen-dependent T cell activation
can strongly occur and induce sufficient levels of IL-2 production. Consequently, the
resulting T cells undergoing IL-2-driven strong proliferative responses showed the ability
to differentiate into functional effector and memory cells that can control infectious
pathogens. These findings therefore reveal previously unappreciated role of IL-2 in driving
the intense form of T cell proliferative responses in chronic lymphopenic hosts.
Keywords: spontaneous proliferation, lymphopenia-induced homeostatic proliferation, naïve CD4 T+ cells, naïve
CD8+ T cells, interleukin-2 (IL-2), specific pathogen-free (SPF), germ-free (GF)
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INTRODUCTION
Proliferation of naïve T cells under lymphopenic
environments has long been accepted as a crucial homeostatic
mechanism by which a diverse repertoire of these cells can be
stably maintained at constant number during their peripheral
life-time (1, 2). Therefore, this proliferative response, also known
as lymphopenia-induced homeostatic proliferation (LIP), is
considered as a common phenomenon for the most polyclonal
and even monoclonal naïve T cell repertoire adoptively
transferred into a recipient animal under various lympho-
depletion settings either genetically (e.g., RAG−/−, TCRβ−/−,
CD3ε−/−, and SCID mice) or conditionally (e.g., mice treated
with irradiation and cytotoxic agents (3–7). The LIP response
in these hosts is relatively slow with 2–3 rounds of cell division
per week and is driven by a signal from self-ligands and elevated
levels of IL-7 (3, 7–10). Despite the slow proliferation is unique
for the LIP response in lymphopenic hosts, the relative strength
of this response can be modulated variably depending on the
cytokines being engaged (11). For instance, the LIP response
driven by IL-2 and/or IL-15 is far stronger than those induced by
IL-7 (12–14).
In sharp contrast to the LIP, however, totally different form
of proliferative responses has also been reported for naïve
T cells when adoptively transferred into the aforementioned
chronic lymphopenic hosts, such as RAG−/− and TCRβ−/−
(or CD3ε−/−) mice (15–17). The proliferative response in these
hosts, known as spontaneous proliferation (SP), is much faster
and stronger than those of typical LIP with more than∼7 rounds
of cell divisions per week and, unlike LIP, is driven in a manner
independent of self-ligands and IL-7 (7, 15). Although the exact
nature of the stimuli for the SP response is still incompletely
understood, it has been demonstrated that this response is
exclusively dependent on largely two key signals, namely
from TCR engagements with its cognate foreign-peptide/major
histocompatibility complex (foreign-pMHC) ligands and also
from costimulatory interactions via CD28 (7, 15). The antigenic
stimuli are thought to be derived from commensal microbiota
because the SP response of naïve T cells is observed only in
RAG−/− hosts raised under the specific pathogen-free (SPF),
but not the germ-free (GF), condition (15). Precisely how the
commensal antigens are presented to stimulate the SP response
of T cells in these hosts and if so, why this phenomenon fails
to occur in other lymphopenic hosts, such as irradiated C57BL/6
(B6) mice, remains to be addressed.
In this respect, recent studies have shown that the role of
commensal microbial antigens in driving the SP response is
not direct but rather indirect effect on T cells via a mechanism
dependent on innate immune stimulation through toll-like
receptor (TLR) on dendritic cells (DCs) (18–20). Therefore, it is
possible that the SP response that occurs in chronic lymphopenic
hosts is regulated at least in part, if not exclusively, by some
forms of antigen-independent responses other than direct TCR
engagements with foreign-pMHC ligands. In fact, it has been
shown that IL-6 produced from DCs that are activated by
bacterial ligands serves as a major driver for promoting the SP
response of naïve T cells adoptively transferred into RAG−/−
hosts (18, 21). However, how these data supporting a role of
antigen-independent components would be reconciled with the
stringent requirement of antigen-dependent components of TCR
stimulation for inducing the robust SP response in chronic
lymphopenic hosts is largely unclear. In this study, we address
these issues by investigating the mechanism of how the SP
response of polyclonal or monoclonal T cells is regulated and
influences their homeostasis and function during their recovery
phase from various settings of lymphopenia. We show here that
the SP response of naïve T cells observed in the lymphopenic
hosts consists of at least two forms of intensive proliferative
responses, namely an antigen-dependent “true” SP response and
an antigen-independent but IL-2-dependent SP-like “bystander”
response.
MATERIALS AND METHODS
Mice
C57BL/6 (B6), B6.PL (Thy1.1), B6.SJL (Ly5.1), Foxp3-eGFP
(22), RAG−/−, L-2+/− mice, all on a B6 background, were
purchased from The Jackson Laboratory. Sources of OT-
I.RAG−/−, HY and SMARTA TCR Tg mice were previously
described (4, 5, 23). Germ free (GF) mice are maintained sterilely
at POSTECH Biotech Center (PBC, Korea) as described (24).
OT-I.RAG−/−.Thy1.1, SMARTA.Thy1.1 and IL-2−/− mice were
generated as described (4, 13). Unless it is described, 6–10
weeks old mice were used for the experiments according to
the protocols approved by the Animal Experimental and Ethic
Committee at the Institute for Basic Science (Korea).
Naïve T Cell Purification
Pooled (inguinal, axillary, cervical, and mesenteric) lymph node
cells from SMARTA TCR Tg or Foxp3-eGFP mice were prepared
for cell sorting as previously described (13, 25), with slight
modifications. In brief, LN cells were first depleted of non-
T cells by using the following biotinylated antibodies; CD11b,
CD11c, CD24, CD19, B220, NK1.1, and IMag according to the
manufacturer’s protocol (BD biosciences). Enriched T cells were
stained with fluorochrome conjugated antibodies to CD8α, CD4,
CD44, CD62L, and/or CD5 and then either Foxp3-eGFP− CD4+
CD44lo CD62L+ (naïve CD4+), CD8α+ CD62L+ CD44 lo (naïve
CD8+), CD8α+ CD62L+ CD44 lo CD5hi CD4− (naïve CD8+
CD5hi), and CD8α+ CD62L+ CD44 lo CD5lo CD4− (naïve CD8+
CD5lo) populations were sorted by using aMoflo XDP (Beckman
Coulter, Brea, CA, USA) to >95% purity.
Adoptive Transfer
After purification, T cells were labeled with 5µM of either
CFSE (Invitrogen) or CellTraceTM Violet (Molecular Probes),
as previously described (26) and injected i.v. into hosts. For
inducing lymphopenia, normal B6 mice were treated with anti-
Thy1.2 mAb 30-H12 (anti-Thy1.2) (Bio X Cell, i.p. injection in
a single dose of 200 µg/mouse, 2 days before cell transfer) or
600cGy of whole-body irradiation (1 day before cell transfer). For
generating antigen-induced “SP-like” response, SMARTA CD4+
T cells were transferred into the hosts, as indicated in the figures,
followed by either LCMV Armstrong (2 × 105 PFU) or LCMV
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peptide GP61−80 (20 µg/mouse) through i.p. injection 1 day post
cell transfer. OT-I CD8+ T cells were transferred into the hosts,
as indicated in the figures, followed by immunization of OVA
protein (Sigma Aldrich, 100 µg/mouse). HY.CD8+ cells from
female HY mice were transferred into female hosts.
Reconstitution of IL-2−/− T Cells
Bone marrow (BM) cells were obtained from B6.SJL (Ly5.1) and
IL-2−/− (Thy1.2) mice, mixed at 1:1 ratio. T cell-depletion was
done in incubating BM cells with anti-CD4 (RL172), anti-CD8
(3.168), anti-CD24 (J11d) on ice for 10 minutes before adding
complement (guinea pig). B6.PL (Thy1.1) mice were lethally
irradiated (9.6Gy) before being injected i.v. with 4 × 106 T cell-
depleted BM cells. At 8 weeks after BM cell transfer, IL-2−/−
naive CD4+ T cells (CD90.2+ CD44lo CD62Lhi CD4+) were
obtained from these mixed chimeras by FACS sorting.
Tissue Preparation
Single-cell suspensions were prepared from mesenteric lymph
nodes (MLNs), lamina propria (LP), epithelium, spleen (SPL),
lung and liver as previously described (24, 27, 28). Briefly, MLNs,
spleen and liver were pressed and filtered through cell strainers.
Small intestine (SI) and large intestine (LI) were harvested and
Peyer’s patches removed prior to process. LP and lung were
digested with collagenase D and DNase I. LP, IEL, and liver
lymphocytes were enriched by 40:75% Percoll density gradient
centrifugation.
Flow Cytometry Analysis
For surface staining, isolated cells were stained for flow cytometry
with the following mAbs from Biolegend, eBioscience and/or
TONBO: CD3 (145-2C11), CD4 (GK1.5 and RM4–5), CD8α (53-
6.7), CD8? (YTS156.7.7), CD44 (IM7), CD45.1 (A20), CD45.2
(104), CD62L (MEL-14), CD69 (H1.2F3), CD90.1 (HIS51 or
OX-7), and TCR H-Y (T3.70) in a conjugation with FITC, PE,
PE-Cy5, PE-Cy7, APC, APC-Cy7 or PB. Propidium iodide (PI)
(Sigma Aldrich) was used at 500 ng/ml of final concentration for
staining of 1–5 × 106 of cells to label dead cells. For intracellular
staining, surface stained cells were fixed and permeabilized
with BD cytofix/cytoperm according to manufacturer’s protocol
(BD Biosciences) and were stained with the following mAbs:
IL-2 (JES6-5H4), IFN-γ (9D3.1C8), TNF-α (MP6-XT22) and
Granzyme B (GB12). Flow cytometry samples were analyzed
using a flow cytometer (LSR Fortessa and Canto-II; BD
Biosciences) with DIVA software. Data were analyzed using
Flowjo (Treestar).
Immunohistochemistry
Small intestine was harvested and Peyer’s patches were removed.
Freshly collected tissues were “snap-frozen” in OCT (Leica)
with liquid nitrogen. Tissue sections (6µm in thickness) were
prepared, air-dried, fixed for 10min at 4◦C in methanol
(Merk). Cryosections were blocked for 30min with biotin
blocking solutions (Invitrogen), washed in PBS, and incubated
overnight at 4◦C with anti-Thy1.1 (OX-7) and anti-CD8α (53–
6.7) antibodies (BioLegend). Sections were then washed with PBS
and stained with DAPI. All slides were mounted with Prolong
Antifade Reagent (Life technologies) and images were capture
with Zeiss LSM 700 CLSM (confocal laser scanning microscope).
Bacteria and Virus Infections
Listeria monocytogenes (LM) strain 10403s, carrying a
recombinant internalin A (InIA) mutant, has been described in
detail previously (29, 30). Briefly, B6 mice were infected with 5
× 1010 CFU Listeria monocytes (LM) InIA-OVA through oral
gavage. For acute infections, B6 mice were infected i.p. with
2× 105 PFU of LCMV Armstrong (31).
Administration of Antibodies and/or
Cytokines in vivo
IL-2/anti-IL-2 complexes were prepared as previously described
(12, 13). In brief, 1 µg of recombinant mouse IL-2 (PeproTech)
was mixed with 5 µg of anti-IL-2 (S4B6) (BD Biosciences) and
injected i.p daily for three consecutive days after adoptive cell
transfer in SPF RAG−/−. For the IL-2 blocking experiments, 100
µg of anti-IL-2 (JES6-1A12) (Bio X Cell) and anti-IL-2 (S4B6)
(BD Biosciences) was injected i.p. every other day for 7 days after
adoptive cell transfer in SPF RAG−/− and B6 hosts.
Intravascular T Cell Staining
Following the previously published protocol (32), 3 µg of anti-
Thy1.1 (OX-7) in 300µl of PBS were injected i.v. into amouse for
intravascular staining of donor OT-I (Thy1.1) CD8+ T cells. The
mice were killed 10min after injection and collected the tissues.
For discrimination of vascular and tissue donor cells, the cells
were stained with ex vivo Abs including anti-Thy1.1 (HIS51).
Statistical Analysis
Results represent the mean ± SEM unless indicated otherwise.
Statistical significance was determined by the unpaired Student’s
t test. Statistical analyses were performed using Prism GraphPad
software v5.0. ∗p< 0.05; ∗∗p< 0.01; ∗∗∗p< 0.001, ∗∗∗∗p< 0.0001;
ns, not significant).
RESULTS
Spontaneous Proliferation of Polyclonal
Naïve T Cells in RAG−/− Hosts
Given the well-known previous observations that polyclonal
naïve CD4+ or CD8+ T cells undergo intense form of
proliferative responses in a Rag-deficient host (15), which
is referred to as spontaneous proliferation (SP), we sought
to address whether and how this SP response of T cells
influences their functional behavior and homeostasis during their
reconstitution from lymphopenia. We thus first confirmed the
prior notion that the SP occurs largely in an antigen-dependent
manner with strong and fast rate of cell division kinetics.
For this, FACS-purified CTV-labeled polyclonal naïve CD4+ T
cells were adoptively transferred into three different lymphopenic
hosts, namely C57BL/6 (B6) mice receiving sub-lethal doses
(600 cGy) of irradiation and Rag1-deficient (RAG−/−) mice
raised under the specific pathogen-free (SPF) or germ-free (GF)
condition (Figure 1A, top). Donor cell division and recovery
from the spleen (SPL) and mesenteric lymph nodes (MLN) were
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FIGURE 1 | Polyclonal naïve CD4+ and CD8+ T cells undergo spontaneous proliferation in RAG−/− hosts. (A) CTV-labeled naïve (Foxp3− CD44lo CD62Lhi)
(CD45.1) CD4+ T cells purified from Foxp3-eGFP mice were intravenously (i.v.) injected into irradiated (600cGy) B6, SPF RAG−/− and GF RAG−/− (CD90.2) hosts
(1 × 106 cells per mouse; top). Mesenteric lymph nodes (MLN) and spleen (SPL) of the recipient mice were analyzed on day 7 by flow cytometry for CTV dilution
(bottom left) and donor cell recovery (bottom right). (B) CTV-labeled naïve (CD44lo CD62Lhi) CD4+ (CD45.1) and CD8+ (CD90.1) T cells were i.v injected either
separately or together into SPF RAG−/− (CD90.2) hosts (1 × 106 cells for each subset per mouse; top). MLN and SPL of the recipient mice were analyzed on day 5
by flow cytometry for CTV dilution (middle) and percentage of spontaneous proliferation (SP) (bottom; mean ± SEM; n = 2–4 mice per group). Data are representative
of at least three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
analyzed on day 7 after adoptive transfer by flow cytometry.
As shown in Figure 1A, donor CD4+ T cells, as expected,
exhibited only ∼2–3 rounds of slow rate of cell division (i.e.,
un-gated CTV+ cells), referred to as lymphopenia-induced
homeostatic proliferation (LIP) that is known to be dependent
on TCR interaction with self-ligands and cytokine IL-7 (3, 7).
In sharp contrast, cells transferred into SPF RAG−/− hosts
showed robust proliferative responses, as evidenced by the full
dilution of CTV dye (i.e., gated CTV− cells); however, these
responses were abrogated substantially in GF RAG−/− hosts,
confirming the previous findings showing stringent dependence
of the SP responses of polyclonal naïve CD4+ T cells on
antigens derived from commensal microbiota (15). Unlike SP, the
slower rate of LIP responses of donor cells was uninterrupted
in the GF RAG−/− hosts, level of which was similar to
that of irradiated B6 hosts (Figure 1A, left; compare un-
gated CTV+ cells in the top and bottom histogram). Thus,
the recovery of donor cells was ∼10-20-fold lower for the
LIP responses in GF RAG−/− and irradiated B6 hosts than
those for the SP responses observed in SPF RAG−/− hosts
(Figure 1A, right). As for the SP of CD4+ T cells, polyclonal
naïve CD8+ T cells from B6 mice also showed robust levels
of SP, albeit at lower extent than CD4+ T cell SP, in SPF
RAG−/− hosts, but not in irradiated B6 hosts (Figure S1),
which was also antigen-dependent because the SP response of
CD8+ T cells was abolished in GF RAG−/− hosts (data not
shown).
Although the above data clearly confirmed the previously
well-defined SP responses of either polyclonal naïve CD4+ or
CD8+ T cells in SPF RAG−/− hosts, interesting findings came
from the experiments in which both naïve CD4+ and CD8+ T
cells were co-transferred into these hosts. As shown in Figure 1B,
in comparison to the proportion of SP responses after single
transfer of either CD4+ or CD8+ T cells (63% ± 3.85 and
48% ± 2.95, respectively for MLN), we observed significantly
enhanced SP responses of CD4+ T cells and to a greater extent
CD8+ T cells on day 7 after co-transfer into SPF RAG−/−
hosts (80% ± 1.92 and 78% ± 1.20, respectively for MLN).
These data suggest that there is a positive cross-talk between
two distinct T cell compartments by which the SP response of
one compartment is facilitated by those of another compartment
during reconstitution period after adoptive co-transfer into SPF
RAG−/− hosts.
Influence of the SP Driven by Polyclonal
CD4+ T Cells on the LIP of TCR Tg CD8+
T Cells
Based on the above findings of such potential cross-talk
between polyclonal naïve CD4+ and CD8+ T cells in SPF
RAG−/− hosts, we then addressed the question of whether
and how the SP responses of two distinct lineages of naïve T
cell populations may affect each of their homeostasis in this
lymphopenic condition. We thus next sought to investigate
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the potential impact of the SP response driven by polyclonal
naïve CD4+ T cell compartment on the typical slow rate
of lymphopenia-induced homeostatic proliferation (LIP)—a
response that is antigen-independent but IL-7-dependent—
of naïve CD8+ T cells co-transferred into SPF RAG−/−
hosts.
For this, we utilized monoclonal TCR transgenic (Tg) CD8+
T cells in order to avoid antigen-dependent SP response, which
was observed for polyclonal B6 CD8+ T cells (Figure 1B), and
validate the true influence of CD4+ T cell-driven strong SP
response on the weak LIP response of monoclonal CD8+ T
cells. Thus, naïve OT-I TCR Tg cells that are specific for H-2Kb-
restricted ovalbumin (OVA) 257-264 peptide were labeled with
CTV and adoptively transferred into irradiated B6 (600 cGy),
SPF RAG−/−, or GF RAG−/− hosts and 7 days later, proliferative
responses of donor OT-I cells were analyzed by flow cytometry
(Figure 2A, top). As shown in Figure 2A, OT-I cells, unlike
polyclonal CD8+ T cells, did not show robust SP responses, but
instead did show only ∼3–4 rounds of the typical slow-rate of
LIP responses in SPF RAG−/− hosts, similar to those seen in
irradiated B6 or GF RAG−/− hosts. Donor cell recoveries in
the spleen were also similar in all three lymphopenic recipients,
although there was a modest difference in the mLN (Figure 2A,
bottom). These data thus confirmed the prior notion that the SP
response observed in RAG−/− hosts is dependent on commensal
microbial antigens and thus detectable only for polyclonal, but
not monoclonal, CD8+ T cells.
Based on the above results showing prevalent occurrence of
the LIP but not the SP upon adoptive transfer with OT-I cells into
SPF RAG−/− hosts, we then investigated the influence of the SP
response driven by polyclonal CD4+ T cells on the LIP response
of OT-I cells. Thus, a mixture of FACS-purified, CTV-labeled
naïve B6 CD4+ T cells and OT-I CD8+ T cells was transferred
into SPF RAG−/− or GF RAG−/− hosts, and as a control, OT-
I cells alone were also transferred into SPF RAG−/− hosts, and
then analyzed on day 8 for their proliferation and cell recovery
(Figure 2B, top). Here, the surprising finding was that, in marked
contrast to the typical slow rate of LIP after single transfer of OT-
I cells alone, these cells showed much faster and greater levels of
proliferative responses when co-transferred with B6 CD4+ T cells
into SPF RAG−/− hosts (Figure 2B, middle). More importantly,
such intense responses of OT-I cells seen in SPF RAG−/− hosts
were not observed in GF RAG−/− hosts even in the presence
of B6 CD4+ T cells being co-transferred, resulting in the poor
donor cell recovery (Figure 2B, bottom). Careful analysis for the
kinetics of these robust proliferative responses revealed that the
appearance of the fast-dividing OT-I cells was apparent from day
4 after co-transfer with B6 CD4+ T cells into SPF but not GF
RAG−/− hosts, a time point of which CD4+ T cells also began to
show significant levels of SP responses (Figure S2), suggesting a
role of B6 CD4+ T cells undergoing SP.
Together, these findings strongly suggest that the SP response
of polyclonal CD4+ T cells in SPF RAG−/− hosts plays a role
in promoting LIP response of co-transferred monoclonal (and
also polyclonal) CD8+ T cells, leading to the alteration of the
speed and degree of their proliferation in a chronic lymphopenic
environment.
Influence of the Polyclonal CD8+ T
Cell-Derived SP on LIP of TCR TG CD8+ T
Cells
Given the above stimulatory effect of the SP response of
polyclonal CD4+ T cells on the LIP of monoclonal OT-I cells
in SPF RAG−/− hosts, we next addressed whether the similar
enhancing effect is also observed with the SP response of
polyclonal CD8+ T cells, because these cells also showed strong
antigen-dependent SP in SPF RAG−/− hosts (Figure 1B and
Figure S1). For this, a mixture of FACS-purified, CTV-labeled
naïve B6 CD8+ T cells and OT-I cells was transferred into SPF
RAG−/− or GF RAG−/− hosts (Figure 3A, top). At day 7 after
adoptive transfer, as expected, B6 CD8+ T cells showed robust SP
responses in SPF but not GF RAG−/− hosts (Figure 3A, middle
and bottom left). Surprisingly, however, such SP responses of B6
CD8+ T cells completely failed to induce strong LIP responses of
the co-transferred OT-I cells in SPF RAG−/− hosts, as evidenced
by the lack of CTV full-diluted, fast-dividing cells in these
recipients, which was comparable to those seen in GF RAG−/−
hosts (Figure 3A, middle and bottom right).
The rather unexpected results from these co-transfer
experiments led us to speculate a possible involvement of clonal
competition within the same lineage of donor CD8+ T cell
populations presumably for self-ligands, and suggest that SP
response of polyclonal T cells in SPF RAG−/− hosts may result
in a diverse degree of LIP differing from one clone to another.
Impact of TCR Affinity for Self-Ligands on
the Strong LIP Response Mediated by the
SP
The above clonal competition for self-antigens within the same
lineage of CD8+ T cell pools is of particular importance to
determine the rate and magnitude of their LIP in lymphopenic
hosts, as has been demonstrated by previous reports (6, 25, 33).
It was thus intriguing for us to test whether the SP response of
polyclonal B6 CD8+ T cells has an enhancing effect on the LIP of
monoclonal CD4+, if not CD8+, TCR Tg cells—in which clonal
competition for self-pMHC ligands is avoided—similar to the
effect observed with B6 CD4+ T cells and OT-I CD8+ T cells in
SPF RAG−/− hosts (Figure 2B).
For this, FACS-purified, CTV-labeled naïve B6 CD8+ T cells
were co-transferred with a mixture of AND TCR Tg (specific for
I-Ek-restricted pigeon cytochrome C 81-104 peptide) and OT-II
TCR Tg (specific for I-Ab-restricted Ova 323-339 peptide) naïve
CD4+ T cells into SPF RAG−/− or GF RAG−/− hosts and 7
days later, the mice were analyzed for donor cell proliferations
by flow cytometry (Figure 3B, top). In marked contrast to the
OT-I CD8+ cells (Figure 3A), AND and to a lesser extent OT-
II CD4+ cells showed a significant increase in the proportion
of their fast-rate of LIP by B6 CD8+ T cells in SPF but not GF
RAG−/− hosts (Figure 3B). Here, the greater effect on the LIP of
AND cells than that of OT-II cells likely reflects the difference in
their relative TCR affinity for self-ligands; thus, the LIP response
was apparently faster and greater for T cells with a high affinity
TCR (i.e., AND cells) than those with a low affinity TCR (i.e.,
OT-II cells) (34).
Frontiers in Immunology | www.frontiersin.org 5 August 2018 | Volume 9 | Article 1907
Kim et al. IL-2-Driven Naive T Cell Proliferation
FIGURE 2 | Rapid LIP response of monoclonal CD8+ T cells is associated with the strong SP response of polyclonal CD4+ T cells in RAG−/− hosts. (A) CTV-labeled
OT-I CD8+ T cells from OT-I.RAG−/− mice (CD90.1) were injected into irradiated (600cGy) B6, SPF RAG−/− and GF RAG−/− (CD90.2) hosts (5 × 105 cells per
mouse; top) and then analyzed on day 7 by flow cytometry for CTV dilution (middle) and donor cell recovery (bottom). (B) CTV-labeled OT-I CD8+ T cells (CD90.1;
5 × 105 cells) were i.v. injected either alone or along with polyclonal naïve CD4+ T cells (CD45.1; 1 × 106 cells) into SPF RAG−/− and GF RAG−/− hosts (CD90.2;
top). MLN and SPL of the recipient mice were then analyzed on days 7-8 by flow cytometry for CTV dilution (middle) and donor cell recovery (bottom). Data shown are
the mean ± SEM (n = 5 mice per group) and are representative of four independent experiments. **p < 0.01; ***p < 0.001; ns, not significant.
As for the above AND and OT-II CD4+ cells, similar
difference was observed with two distinct CD8+ TCR Tg cells,
namely OT-I vs. HY (specific for H-2Db-restricted male antigen-
derived peptide), in which their intrinsic TCR affinity for self-
ligands is much lower in HY cells than in OT-I cells (5, 6, 35).
Thus, the results again clearly showed that the enhancing effect
on the LIP was much greater for OT-I cells than for HY cells,
when these cells were co-transferred with B6 CD4+ T cells into
SPF RAG−/− hosts (Figure S3A). Likewise, the enhancing effect
on the LIP of OT-I cells was also further confirmed together with
co-transfer of P14 TCR Tg CD8+ T cells (specific for H-2Db-
restricted lymphocytic choriomeningitis virus glycoprotein 33-
41 peptide) into SPF RAG−/− hosts (Figure S3B). These results
thus suggest that the effect we observed is not OT-I-specific
but broadly applicable for different monoclonal CD8+ T cell
populations with variable degrees depending on their relative
TCR affinity for self-ligands.
Together, these findings indicate that the SP response of
either polyclonal CD4+ or CD8+ T cells in SPF RAG−/− hosts
contributes to promoting the faster and greater LIP response
of CD8+ or CD4+ T cells, respectively, in a TCR-self-MHC
dependent manner.
Effect of Ag-Specific CD4+ T Cell
Activation on the CD8+ T Cell LIP in Acute
Lymphopenic Conditions
The above data so far pointed out the unique ability of
polyclonal T cells to promote the strong LIP of TCR Tg
cells only when the former induces robust SP response in
a chronic severe lymphopenic host such as SPF RAG−/−
mice. Because the SP response in these hosts was commensal
microbial antigen-dependent and thus failed to occur in a
GF condition, it is possible that the above phenomenon
is limited to a particular condition of SPF RAG−/− mice
rather than a general occasion of typical lympho-depleted
mice through irradiation, cytotoxic drugs, or T cell-depleting
antibodies.
We thus sought to address this issue of whether antigen-
induced strong T cell responses would also facilitate the rate
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FIGURE 3 | The SP response of polyclonal CD8+ T cells promotes the rapid LIP response of CD4+ but not CD8+ T cells. (A) A mixture of CTV-labeled polyclonal
naïve CD8+ T cells (CD45.1; 1 × 106 cells) and OT-I CD8+ T cells (CD90.1; 5 × 105 cells) was injected into SPF RAG−/− and GF RAG−/− hosts (CD90.2; top).
MLN and SPL of the mice were then analyzed on day 7 by flow cytometry for CTV dilution (middle) and percentages of the SP of polyclonal CD8+ T cells (CD8+ SP;
bottom left) and of the fast-dividing lymphopenia-induced proliferation (LIP) of OT-I cells (OT-I fast LIP; bottom right). (B) A mixture of CTV-labeled polyclonal naïve
CD8+ T cells (CD45.1; 2 × 106 cells) and either AND CD4+ T cells from AND.RAG−/− mice (CD90.1; 1 × 106 cells) or OT-II CD4+ T cells from OT-II.RAG−/− mice
(CD90.1/90.2; 1 × 106 cells) was injected into SPF RAG−/− and GF RAG−/− hosts (CD90.2; top) and then analyzed on day 7 by flow cytometry for CTV dilution
(middle) and percentages of the fast-dividing LIP of AND and OT-II CD4+ T cells (bottom). Data shown are the mean ± SEM (n = 3–4 mice per group) and are
representative of three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant.
and intensity of LIP of naïve CD8+ T cells (either from
B6 and TCR Tg mice). For this, we generated two different
lymphopenic settings derived from normal B6 mice by treatment
of either a sub-lethal dose of irradiation (Figure 4A) or a
monoclonal antibody against Thy1.2 for depleting host T cell
compartment (anti-Thy1.2mAb; clone 30H12; Figure 4B). In the
first lymphopenic setting, normal B6 hosts receiving irradiation
(600 cGy) were adoptively transferred with B6 CD8+ T cells
either alone or together with SMARTA TCR Tg CD4+ T cells
(specific for I-Ab-restricted lymphocytic choriomeningitis virus
glycoprotein 61-80 peptide; LCMV GP61) and 1 day later,
were immunized with LCMV GP61 peptide antigen (Figure 4A,
top); noted that the peptide antigen must be used here as
a stimulus for SMARTA cells, because LCMV infection was
lethal for the irradiated mice. Thus, while donor B6 CD8+ T
cells showed only a typical slow rate of LIP response when
transferred alone with peptide injection, interesting finding was
that these CD8+ cells showed significantly elevated levels of
rapidly dividing cells when SMARTA cells were co-transferred
and activated with its cognate peptide antigen LCMV GP61
(Figure 4A, bottom). Here, the rather smaller increase of the
fast-dividing donor B6 CD8+ T cells in irradiated B6 hosts
with activated SMARTA cells (∼37–52%; Figure 4A) relative
to those of donor OT-I cells in SPF RAG−/− hosts with B6
CD4+ T cells (∼78–80%; Figure 2B) might reflect a diverse
range of heterogeneity in polyclonal CD8+ T cell pools for
their TCR affinity to self-ligands. In light of this view, we
indeed found that the extent of the fast-rate of LIP driven
by peptide-stimulated SMARTA cells in irradiated B6 hosts
was much higher for CD5hi donor B6 CD8+ T cells than
for CD5lo counterparts co-transferred (∼76–79% vs. ∼13–14%,
respectively; Figure S4). The data thus suggest a role of the
activated CD4+ T cells (here SMARTA cells) in promoting the
rate and degree of antigen-independent LIP response of naïve
CD8+ T cells even in an irradiation-induced, acute lymphopenic
condition.
To further confirm the above findings, we then utilized
the second alternative approach in which normal B6 mice
were injected with anti-Thy1.2 mAb (30H12) to acutely deplete
host T cell compartment. The mAb-treated mice were then
adoptively transferred with OT-I CD8+ T cells either alone or
along with SMARTA CD4+ T cells, followed by either being
un-infected or infected with LCMV to stimulate the latter
SMARTA cells specifically (Figure 4B, top). Consistent with
the results from the above irradiation-induced lymphopenic
settings, the increased proportion of rapidly dividing OT-I
cells was prominent with LCMV infection and subsequent
activation of co-transferred SMARTA cells, whereas there was
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FIGURE 4 | Antigen-induced SP response of CD4+ T cells enhances the fast-dividing LIP of CD8+ T cells in various lymphopenic settings. (A) B6 mice (CD90.2)
were treated with a sub-lethal dose of irradiation (600 cGy) 1 day before cell transfer and then injected i.v. with CTV-labeled polyclonal naïve CD8+ T cells (CD45.1;
5 × 105 cells) either alone or along with naïve SMARTA CD4+ T cells from SMARTA TCR Tg mice (CD90.1; 5 × 104 cells) and 1 day later, immunized intraperitoneally
(i.p.) with LCMV peptide GP61−80 (top). MLN and SPL were analyzed on day 7 by flow cytometry for CTV dilution (bottom left two panels) and percentages of the fast
LIP of donor CD8+ T cells (bottom right). (B) B6 mice (CD90.2) were injected i.p. with anti-Thy1.2 mAb (30H12) 2 days before cell transfer and then injected i.v. with
CTV-labeled OT-I CD8+ T cells (CD90.1; 5 × 105 cells) either alone or along with SMARTA CD4+ T cells (CD90.1; 5 × 104 cells) and 1 day later, injected i.p. either
with PBS or with LCMV Armstrong (2 × 105 PFU; top). MLN and SPL were analyzed on day 7 by flow cytometry for CTV dilution (bottom left two panels) and
percentages of the fast LIP of donor OT-I cells (bottom right). Data shown are the mean ± SEM (n = 3-4 mice per group) and are representative of at least three
independent experiments. *p < 0.05; **p < 0.01; ns, not significant.
no such increase of OT-I cell proliferation by SMARTA
cells without LCMV infection (∼43% vs. ∼5–6%, respectively;
Figure 4B, bottom two rows). As a control, there was only
a slow rate of LIP of OT-I cells without SMARTA cells
regardless of LCMV infection (Figure 4B, middle two rows);
however, noted that, albeit at a smaller portion, LCMV infection
appears to have a tendency of slight increase of OT-I cell
LIP in this T-depleted condition, presumably due to some
innate responses derived from residual host-derived, non-T cell
populations.
The above effects on the OT-I cell LIP driven by the
antigen-stimulated SMARTA cells were all observed in acute
lymphopenic conditions (Figures 4A,B). Importantly, however,
these effects were not detected in normal lympho-replete hosts;
thus, upon LCMV infection without 30H12 mAb-induced
lymphopenia, both the slow- and the fast-responding LIP of OT-I
cells were severely decreased (Figure S5), therefore highlighting
a stringent requirement of lymphopenia. Collectively, these
findings strongly suggest that the above phenomenon seen in
SPF RAG−/− hosts is not due to their unique environment
of chronic lymphopenia. Instead, the elevated levels of the
fast-rate LIP of naïve CD8+ T cells can efficiently occur
under various forms of acute lymphopenic conditions if two
key requirements are provided, namely CD4+ T cells and
their specific cognate antigens capable of stimulating these
cells.
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FIGURE 5 | The fast-dividing LIP response is independent of both IL-7 and IL-15 but is dependent on IL-2. (A) Wild-type (B6) and IL-7.IL-15 double knock-out (DKO)
mice (CD90.2) were injected i.p. with anti-Thy1.2 mAb (30H12) 2 days before cell transfer (top). These mice were then injected i.v. with CTV-labeled OT-I CD8+ T cells
(CD90.1; 5 × 105 cells) either alone or along with SMARTA CD4+ T cells (CD90.1; 5 × 104 cells) and 1 day later, infected i.p. with LCMV Armstrong (2 × 105 PFU).
CTV dilution (bottom left) and percentages of the fast LIP of donor OT-I cells (bottom right) were analyzed on day 8 by flow cytometry. (B) B6 mice treated with 30H12
mAb were injected i.v. with a mixture of CTV-labeled OT-I CD8+ (CD90.1; 5 × 105 cells) and SMARTA CD4+ T cells (CD90.1; 5 × 104 cells) and then infected i.p.
with LCMV Armstrong (2 × 105 PFU; top). These mice were injected i.p. either with PBS or anti-IL-2 mAbs (two clones; JES6-1 and S4B6) at the indicated time points
(top). CTV dilution (bottom left) and percentages of the fast LIP of donor OT-I cells (bottom right) were analyzed on day 8 by flow cytometry. Data shown are the mean
± SEM (n = 3 mice per group) and are representative of at least three independent experiments. *p < 0.05; **p < 0.01.
Role of IL-2 in Promoting Strong LIP
Response in Acute Lymphopenic Hosts
The above findings that the stimulated CD4+ T cells under acute
lymphopenic settings led to the faster and greater LIP of CD8+
T cells prompted us to elucidate its underlying mechanisms and
raise the question of how this is regulated and which factor
is involved. Based on the fact that the LIP of naïve CD8+ T
cells is known to be antigen-independent and largely driven by
cytokines, especially IL-7 (or both IL-7 and to a lesser extent
IL-15 for naïve CD4+ T cells) (7, 10), it is possible that the
enhanced LIP response was just a mere reflection of greatly
increased levels of these cytokines, presumably accompanied
by the antigen-dependent activation of CD4+ T cells in this
condition.
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We therefore tested this possibility of a role of the elevated
amounts of IL-7 and/or IL-15 as a mechanism of promoting the
antigen-independent strong LIP of CD8+ T cells after LCMV
infection. For this, a mixture of SMARTA CD4+ and OT-I CD8+
T cells was adoptively transferred into the aforementioned T-
depleted lymphopenic B6 mice (using 30H12 mAb treatment)
of either wild-type (WT) or double knock-out (DKO) for both
IL-7 and IL-15, and 1 day later, the mice were infected with
LCMV and analyzed on day 7 by flow cytometry (Figure 5A,
top). Here, the notable finding was that the enhancing effect
on the LIP of OT-I cells was prominent with LCMV-activated
SMARTA cells for both WT and DKO hosts compared to
that of OT-I cells without SMARTA cells (Figure 5A, bottom),
implying a role of different factor(s) other than IL-7 and IL-
15.
In an attempt for searching the key factor(s), we then tested
a possible role of IL-2 because this cytokine is mainly produced
from T cells after antigenic stimulation. Moreover, especially for
naïve CD8+ T cells, IL-2 is known to induce an intense form
of antigen-independent, rapid proliferative response in both
lympho-deplete and even lympho-replete conditions (13). To
address a role of IL-2, the 30H12-treated B6mice were adoptively
transferred with a mixture of SMARTA and OT-I cells and 1 day
later, infected with LCMV in the presence or absence of anti-
IL-2 mAbs (JES6-1 and S4B6 clones) for blocking in vivo IL-
2, and then analyzed on day 8 by flow cytometry (Figure 5B,
top). Here, the result was surprising; while the OT-I cells co-
transferred with SMARTA cells showed the elevated proportion
of the fast-dividing LIP, these cells failed to do so after LCMV
infection along with IL-2 blockade (Figure 5B, bottom). The data
thus suggest that the enhancing effect of the antigen-activated
CD4+ T cells on the LIP of CD8+ T cells was associated at least
in part with in vivo activity of IL-2.
Role of IL-2 in Enhancing Strong LIP
Response in SPF RAG−/− Hosts
The implication of the above results with IL-2 blockade is that the
IL-2 may act as a key factor and is produced by LCMV-activated
SMARTA CD4+ T cells, a level of which is perhaps sufficient to
promote the rapid and robust form of antigen-independent LIP
of co-transferred OT-I CD8+ T cells in T-depleted hosts. Given
the close similarity in the requirement of antigen-induced CD4+
T cell activation, we reasoned that the enhancing effect on the
LIP of OT-I cells observed in SPF RAG−/− hosts (Figure 2B)
might also be mediated via a mechanism that is dependent on IL-
2 presumably produced from activated CD4+ T cells undergoing
SP in these hosts.
We therefore tested again this possibility and the results
were indeed the case with the following two observations: (1) a
decrease and (2) an increase in the fast-dividing LIP by blocking
or enhancing in vivo IL-2 activity, respectively (Figure 6A
and Figure S6A). For this, SPF RAG−/− mice were adoptively
transferred with either OT-I cells alone or a mixture of OT-I cells
and B6 CD4+ T cells, and then untreated or treated either with
anti-IL-2 mAbs for blocking IL-2 (Figure 6A, top) or with IL-2
as a form of IL-2 and anti-IL-2 (S4B6) immune complex known
to enhance IL-2 activity in vivo (Figure S6A) (12, 36). Here, the
result was that OT-I cells co-transferred with B6 CD4+ T cells
failed to show the fast-dividing LIP after IL-2 blockade, while
undergoing the slow-rate of LIP similar to those seen inOT-I cells
transferred alone (Figure 6A, bottom). Conversely, however, the
lack of the fast-rate LIP of OT-I cells transferred alone was
completely restored after treatment with IL-2/anti-IL-2 complex,
to the level comparable to those seen in OT-I cells co-transferred
with B6 CD4+ T cells (Figure S6A). Moreover, these IL-2/anti-
IL-2 complexes also induced the faster and greater LIP of OT-I
cells even when co-transferred with competing B6 CD8+ T cells
into SPF RAG−/− hosts (Figure 3A and Figure S6B). Besides
these findings with OT-I cells, we also obtained similar data for
polyclonal B6 CD8+ and CD4+ T cells co-transferred into SPF
RAG−/− hosts with or without blocking IL-2 (Figure 6B); here,
again, the in vivo IL-2 blockade led to ∼26-62% of significant
reduction of the fast-dividing CD4+ and CD8+ T cells in these
hosts.
We further confirmed the data from the above blocking
experiments with anti-IL-2 mAb to validate the role of IL-2
produced by CD4+ T cells undergoing SP in SPF RAG−/−
hosts. For this, we first generated bone marrow (BM) chimera
reconstituted with a 50:50 ratio of WT and IL-2−/− BM cells to
avoid spontaneous T cell activation due to autoimmunity in IL-
2−/− mice (37) and 8 weeks later, naïve CD4+ T cells derived
fromWT and IL-2−/− BM were isolated from the chimeric mice
(Figure S6C). OT-I cells were then adoptively transferred alone
or co-transferred with either the WT or the IL-2−/− CD4+ T
cells into SPF RAG−/− hosts and analyzed on day 7 by flow
cytometry (Figure 6C, top). While the fast-dividing LIP of OT-
I cells was apparent with WT CD4+ T cells, this response was
totally abolished with IL-2−/− CD4+ T cells despite their SP
response was relatively intact (Figure 6C, bottom). Consistent
with this finding, our data from additional transfer experiments
also revealed that rapidly dividing activated CD4+ T cells in SPF
RAG−/− hosts indeed show a profound synthesis of intracellular
IL-2 (and IFN-γ) after short-term in vitro restimulation, a level
of which was much higher than that of OT-I cells co-transferred
(Figure S7).
Together, all these findings strongly support the notion that
IL-2 is produced from polyclonal CD4+ (and CD8+) T cells
that are activated as a result of antigen-dependent SP response
in SPF RAG−/− hosts, which then acts as a key player for
promoting the rapid and robust form of antigen-independent,
but IL-2-dependent LIP of monoclonal CD8+ T cells in these
hosts.
Effector Activity of IL-2-Driven Strong LIP
Response Against Bacterial Infection
Given the above data showing the strong proliferation
of CD8+ T cells driven by IL-2 that is produced from
antigen-stimulated CD4+ T cells co-transferred into either
a chronic or an acute lymphopenic host, we next sought to
address whether these robust form of antigen-independent,
IL-2-driven response is functionally relevant for immune
responses.
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FIGURE 6 | The fast-dividing LIP is mediated by IL-2 produced as a result of the SP response of CD4+ T cells. (A) CTV-labeled OT-I CD8+ T cells (CD90.1; 5 × 105
cells) either alone or along with polyclonal naïve CD4+ T cells (CD45.1; 1 × 106 cells) were injected i.v. into SPF RAG−/− hosts (CD90.2; top). The mice were then
injected i.p. either with PBS or with anti-IL-2 mAbs (JES6-1 and S4B6) at the indicated time points (top). CTV dilution (bottom left) and percentages of the fast LIP of
donor OT-I cells (bottom right) were analyzed on day 7 by flow cytometry. (B) A mixture of CTV-labeled polyclonal naïve CD4+ (CD45.1; 1 × 106 cells) and CD8+ T
cells (CD90.1; 1 × 106 cells) was injected i.v. into SPF RAG−/− hosts (CD90.2) and then treated i.p. with either PBS or anti-IL-2 mAbs (JES6-1 and S4B6) at the
indicated time points (top). MLN and SPL were analyzed on day 5 by flow cytometry for CTV dilution (middle) and percentages of the fast LIP of donor CD4+ and
CD8+ T cells (bottom). (C) CTV-labeled OT-I CD8+ T cells (CD90.1; 5 × 105 cells) either alone or along with polyclonal naïve CD4+ T cells (1 × 106 cells) purified
from either wild-type B6 (CD90.1) or IL-2-deficient (IL-2 KO; CD90.2) mice were injected i.v. into SPF RAG−/− hosts (CD90.2; top). MLN and SPL of the recipient
mice were then analyzed on day 7 by flow cytometry for CTV dilution (bottom left two panels) and percentages of the fast LIP of donor OT-I cells (bottom right). Data
shown are the mean ± SEM (n = 3 mice per group) and are representative of three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001.
For this, SPF RAG−/− hosts were adoptively transferred
with either a mixture of OT-I cells and B6 CD4+ T cells
or as a control OT-I cells alone, and for the latter control
group, were either un-immunized or immunized with OVA
antigen, and then analyzed on day 7 by flow cytometry
(Figure 7A, top). Here, as expected, donor OT-I cells co-
transferred with B6 CD4+ T cells showed robust expansion
and thus their recoveries from blood, SPL, lung and liver were
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FIGURE 7 | IL-2-driven strong LIP response leads to the protective immunity against bacterial infection. (A,B) OT-I CD8+ T cells (CD90.1; 5 × 105 cells) were injected
i.v. either alone or along with polyclonal naïve CD4+ T cells (CD90.1 or CD45.1; 1 × 106 cells) into SPF RAG−/− hosts (CD90.2; top). The mice were then either left
with PBS injection or immunized i.p. with OVA protein (100 µg/mouse) and analyzed on day 14 (top). The various lymphoid organs indicated were analyzed for donor
cell recovery by flow cytometry (A; bottom) and for donor cell migration to the small intestine (SI) by immunofluorescence histochemistry with antibodies specific for
DAPI (blue), anti-Thy1.1 (red), and anti-CD8α (green; B). Data shown in (A) are the mean ± SEM (n = 4–6 mice per group). Representative immunofluorescence
images from three independent experiments are shown (B). (C–E) B6 mice (CD90.2) were treated i.p. with anti-Thy1.2 mAb (30H12) 2 days before cell transfer and
then injected i.v. with OT-I CD8+ T cells (CD90.1; 5 × 105 cells) either alone or along with SMARTA CD4+ T cells (CD90.1; 5 × 104 cells) and l day later, immunized
i.p. either with LCMV Armstrong (2 × 105 PFU) or with OVA protein (100 µg/mouse; top). At 56 days after adoptive transfer, the mice were then challenged with
OVA-expressing Listeria monocytogenes (LM-OVA) via oral gavage (5 × 1010 CFU; top). The mice were analyzed on day 7 post-challenge for donor OT-I recovery
from the SPL and SI (for intraepithelial lymphocytes; IEL) by flow cytometry (C), and were monitored at the indicated time points for body weight loss and survival (D),
and also measured for bacterial counts in the SI and liver by plaque assay (E). Data shown are the mean ± SEM (n = 5 mice per group) and are representative of
three independent experiments. *p < 0.05; ***p < 0.001.
significantly greater than those of OT-I cells transferred alone
without immunization (Figure 7A, bottom left). Importantly,
the degree of expansion and recovery of OT-I cells were
as near similar when co-transferred with B6 CD4+ T cells
as those of OT-I cells when transferred alone with OVA
stimulation, and in particular, were also prominent in the gut-
associated lymphoid tissues such as mLN, small, and large
intestine (SI and LI, respectively) (Figure 7A, bottom right).
Such preferential recovery of donor OT-I cells from the SI,
especially intraepithelium (IEL) was also further confirmed by
immunofluorescent tissue staining (Figure 7B). Furthermore,
in line with the greater expansion, we found that the OT-I
cells co-transferred with B6 CD4+ T cells into SPF RAG−/−
hosts exhibited a high expression of granzyme B as well as an
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ability to produce IFN-γ and TFN-α upon short-term in vitro
restimulation, characteristics of differentiation into functional
effector cells (Figure S8A).
Based on the appearance of functional effector CD8+ cells
driven by IL-2 after co-transfer with B6 CD4+ T cells into SPF
RAG−/− hosts, we then investigated whether the similar events
of effector differentiation would occur and also develop into
functional memory cells in the aforementioned acute T cell-
depleted hosts with LCMV infection, a phenomenon that is
also likely to be IL-2 dependent (Figure 5B). For this, 30H12-
treated, T cell-depleted B6 mice were adoptively transferred with
OT-I cells either alone or along with SMARTA cells, and then
immunized with either LCMV or as a control OVA antigen
(only for hosts receiving OT-I cells alone) (Figure 7C, top). At
2 months later, the mice were infected via oral gavage with
internalin A (InlA)-mutated Listeria monocytogenes expressing
OVA antigen (LM-OVA; Figure 7C, top), a mutant strain that is
restricted to the intestinal infection through gut epithelial cells
(29, 30). Here, at day 7 after LM-OVA challenge, the percentage
and recovery of donor OT-I cells that had been primed with
LCMV-stimulated SMARTA cells were as prominent in the SPL
and to a much greater extent SI-IEL as those of OT-I cells that
had been primed by OVA antigen, but much greater than those
of OT-I cells that had been primed irrelevantly with LCMV in
the absence of SMARTA cells (Figure 7C, bottom). Likewise, the
OT-I cells from the former two groups of recipients also showed
much higher ability to synthesize granzyme B and produce
IFN-γ and TFN-α after in vitro restimulation (Figure S8B).
Most importantly, in line with such prominent memory recall
responses, OT-I cells that had been primed with LCMV-activated
SMARTA cells resulted in the strong protective responses against
lethal doses of LM-OVA challenges, comparable to those of OT-I
cells that had been primed with OVA antigen, as evidenced by the
smaller body weight reduction, higher survival rates, and lesser
bacterial counts than those of control OT-I cells that had been
un-primed (Figures 7D,E).
Collectively, these data indicate that the IL-2-driven, robust
LIP response of CD8+ T cells that is associated with antigen-
dependent activation of CD4+ T cells under lymphopenic
conditions is accompanied by efficient generation of and
differentiation into effector and memory cells that are functional
for protecting hosts from pathogenic infections.
DISCUSSION
Unlike the slow rate of lymphopenia-induced homeostatic
proliferation (LIP), the rapid and robust form of proliferative
responses has been documented for naïve T cells particularly
in a chronic lymphopenic host such as RAG−/− and TCRβ−/−
(and also CD3ε−/−) mice (15, 17). Although this response
(called as spontaneous proliferation; SP) is known to be antigen-
dependent—an antigen derived from commensal microbiota,
precise nature of this response and its impact on homeostasis and
function for the responding T cells during their recovery from
lymphopenia remain incompletely understood. In the present
study, we addressed these issues and demonstrated that, upon
adoptive transfer of polyclonal B6 naïve CD4+ and CD8+ T
cells into SPF but not GF RAG−/− hosts, strong SP response of
these cells affects the intensity and the tempo of the responding
T cells, especially for those of undergoing antigen-independent
LIP. Thus, the resulting LIP response in SPF RAG−/− hosts
was rapid and intense, and was influenced by TCR affinity for
self-ligands and most importantly, heavily dependent on IL-2
that is produced from activated T cells undergoing antigen-
dependent SP. Notably, these observations were not limited to a
unique environment of chronic lymphopenia but rather broadly
applicable for various other acute lymphopenic conditions with
two crucial requirements, namely antigen-dependent T cell
activation and availability of relatively high amounts of IL-2. As a
consequence, T cells undergoing IL-2-driven strong LIP showed a
full capacity to differentiate into functional effector and memory
cells that can provide a protective response against pathogenic
bacterial infection.
The exact nature of stimuli for driving the strong SP
response in RAG−/− hosts is unclear but a number of evidence
revealed that this response mainly depends on a strong TCR
signal via its engagement with a cognate antigen—presumably
from commensal microbial components—and also costimulatory
signal through CD28 (15, 18, 38, 39). Such dependency explains
why the SP response occurs only with polyclonal but not
monoclonal T cell populations, and is undetectable in GF
RAG−/− hosts or severely reduced even in SPF RAG−/− hosts
after treatment with antibiotics (15, 18). This notion therefore
seems to fit well with the idea that the SP response by polyclonal
naïve CD4+ or CD8+ T cells in SPF RAG−/− hosts is a reflection
of strong responsiveness of a few, albeit rare, clones that have
specificity to a variety of commensal-derived peptide antigens.
In fact, it has been shown that for CD4+ T cells, the SP
response is impaired in chronic lymphopenicmice lackingMHC-
II expression (15, 17) but unimpaired in mice either being treated
with mAb for blocking IL-7 or lacking IL-7 expression (7, 40, 41).
Given this notion, our data showing enhanced SP response of B6
CD4+ and CD8+ T cells co-transferred into SPF RAG−/− hosts
compared to those of either CD4+ or CD8+ T cells transferred
separately were rather unexpected (Figure 1B), because these
cells were unlikely to share TCR specificity for cognate antigens
and they were subjected to strong activation independently in an
antigen-specific manner.
Based on the findings from the above co-transfer experiments,
it was tempting to speculate that the SP response is perhaps
influenced at least in part by a factor other than TCR engagement
with cognate antigens. This prediction was indeed true and
supported by the following two surprising observations: the rapid
and robust “SP-like” proliferative responses of (1) OT-I TCR
Tg CD8+ T cells co-transferred with B6 CD4+ T cells and (2)
AND TCR Tg CD4+ T cells co-transferred with B6 CD8+ T cells
into SPF RAG−/− hosts (Figures 2B, 3B). Because there are no
cognate antigens specific for OT-I and AND cells, such robust
proliferations of these cells we observed in SPF RAG−/− hosts
appear to rule out a role of antigen-dependent signals through
OT-I or AND TCR per se. However, despite the lesser importance
of antigen-specific TCR engagement, the robust responses of
TCR Tg cells in SPF RAG−/− hosts still depend on a covert
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TCR signal derived from its contacts with self-ligands. Thus, the
reduced proliferative responses were apparent with monoclonal
or polyclonal T cells of lower TCR affinity for self-ligands, e.g.,
HY or OT-II cells and B6 CD5lo cells transferred into SPF
RAG−/− hosts (compared to those of OT-I or AND cells and
B6 CD5hi cells, respectively; Figure 3B and Figures S3A, 4). In
this respect, the observed self-dependence of these TCR Tg cells
and relative difference in their proliferative response in SPF
RAG−/− hosts closely resemble those seen with these cells in
acute lymphopenic hosts (7, 8), although the intensity and tempo
of the proliferative responses are distinctly different. Hence, the
logical explanation for the proliferative response of monoclonal
TCR Tg cells driven by polyclonal T cells in SPF RAG−/− hosts is
that this phenomenon falls into the same category as the typical
IL-7-driven LIP response in that the response occurs (1) only
in lymphopenic conditions; depends (2) on TCR engagement
with self-ligands; and is (3) independent of cognate antigenic
stimulation. But the difference is that the former is much faster
and stronger than the latter LIP and is driven by a combination
of two important stimuli, namely a tonic TCR self-reactivity and
presumably a much more potent cytokine than IL-7.
In an attempt to search for the latter cytokine factor that
has a stimulatory activity, IL-2 is the most suitable candidate.
This prediction is based on our findings that the robust LIP of
TCR Tg cells in SPF RAG−/− hosts is stringently dependent on
the presence of polyclonal B6 T cells and their strong activation,
likely inducing effector cells capable of producing IL-2. In fact,
we and others have previously shown that IL-2 acts as a potent
stimulator for naïve CD8+ T cells by itself even in the absence of
antigenic stimulation both in vitro and in vivo (35, 42). Moreover,
this cytokine—either alone or along with IL-15—was shown to
induce much intense form of proliferative responses for naïve T
cells in lympho-deplete or even lympho-replete hosts (12, 35, 43),
the intensity and tempo of which are similar to those of the
strong LIP response we observed in SPF RAG−/− hosts. Because
these previous studies, however, utilized an experimental setting
in which naïve T cells are exposed to a supraphysiological level
of IL-2 in a rather unphysiological condition, a role of IL-2 was
needed to be validated in our system. In this regard, two critical
questions arise: (1) does IL-2 indeed act as a key stimulatory
factor? and (2) are polyclonal B6 T cells that are activated and
proliferated in SPF RAG−/− hosts a major source for in vivo IL-2
production? These were indeed the case and clearly supported by
a series of our in vivo data showing a decrease of the robust LIP
response of OT-I cells by IL-2 blockade (Figure 6A), an increased
response by IL-2 administration (Figures S6A,B), and finally an
impaired response when co-transferred with IL-2−/− CD4+ T
cells (Figure 6C). Although a stimulatory role of IL-2 was better
highlighted with TCR Tg cells (here OT-I cells), it should be
noted, however, that the effect by IL-2 was also prominent for
polyclonal B6 T cells (Figure 6B). Thus, the reduction of the
strong proliferative responses by IL-2 blockade was apparent for
both B6 CD8+ and to a lesser extent CD4+ T cells. Why the B6
CD4+ T cells were less effective for the IL-2 blockade is unclear.
Whether this is a reflection of less contribution of IL-2-driven LIP
yet more reliance on antigen-driven SP for CD4+ T cells than for
CD8+ T cells remains to be addressed.
Based on the above effect of IL-2, it seems conceivable
that the typical SP response of polyclonal B6 T cells in SPF
RAG−/− hosts largely consists of at least two different forms
of proliferation, namely an antigen-dependent “true” SP as
well as an antigen-independent and IL-2-dependent “bystander”
LIP, with its strength and rate of proliferation akin to those
of the SP. In light of this notion, it should be taken into
caution that the SP response reported in some previous
studies utilizing co-transfer experiments of polyclonal CD4+
and CD8+ T cells into the same chronic lymphopenic hosts
might include such a bystander component of IL-2-driven rapid
LIP. Because this response in these hosts occurs in a manner
independent of TCR engagement with cognate antigens, T cells
(especially for CD8+ T cells) would be strongly responding
and proliferating even in a situation where MHC-I expression
is limited or absent if MHC-II expression is intact for CD4+
T cells to drive their SP and IL-2 production. In fact, a
previous study has shown that, when transferred with an
unseparated mixture of naïve CD4+ and CD8+ T cells, the
strong proliferative response of the latter population is found
even in MHC-I-deficient TCRβ−/− hosts and concluded that
this phenomenon is MHC-II-, but not MHC-I-, dependent
(17). In this situation, however, determining whether the
observed response of CD8+ T cells in an MHC-I-lacking
environment would reflect the effect of IL-2 produced from
the co-transferred antigen-activated CD4+ T cells will be
interesting.
How IL-2 can induce such a robust SP-like bystander
response is unclear. Previously we have addressed this issue
and demonstrated that IL-2 (or IL-15) has a unique ability to
drive activation and proliferation of naïve T cells, particularly
CD8+ T cells, via a mechanism dependent on the density
of lipid rafts on the T cell membrane (35). In this study, a
relatively high concentration of IL-2 in vitro could induce a
rapid membrane relocalization and clustering of IL-2Rβ chain
(CD122) into the membrane micro-domains of lipid rafts,
leading to the enhanced activation and amplification of IL-
2R and its downstream signal transduction pathways, including
activation of JAK/STAT, ERK, and PI3K/AKT signaling pathways
(35). Hence, the implication from these studies is that naïve
CD8+ T cells (and to a lesser extent CD4+ T cells) are able
to undergo rapid SP-like responses only when these cells are
exposed to IL-2 at high concentrations and that this response
may occur in any situation where IL-2 is increased at sufficiently
high levels in vivo. Inducing IL-2 production may be easily
achieved by strong antigenic stimulation of naïve T cells,
yet reaching an effective concentration at levels sufficient for
inducing robust SP-like response seems less easy largely because
of shorter half-life of in vivo IL-2 and its rapid consumption
by overwhelming numbers of T cells being expanded during
antigen-specific immune responses. Indeed, we found that, upon
adoptive transfer of OT-I cells into normal lympho-replete B6
hosts, potent antigenic stimulation of either polyclonal B6 (host-
derived) or monoclonal SMARTA CD4+ T cells (co-transferred)
triggered by LCMV infection fails to induce IL-2-driven strong
proliferative responses of OT-I cells (Figure S5). The result,
however, was totally different when such antigenic stimulation
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occurs in a lympho-deplete condition, resulting in the robust IL-
2-dependent SP-like response of OT-I cells (Figures 4, 5). Our
findings therefore provide strong support for the notion that
such robust proliferative responses of naïve T cells can be easily
driven by relatively increased levels of in vivo IL-2 produced from
antigen-stimulated T cells in both situations of chronic and acute
lymphopenia.
Our study presented here does not rule out the possibility
that the IL-2 may function indirectly through CD4+ T cells
or DCs rather than direct action on CD8+ T cells (19).
Here, the possible scenario is that IL-2 may modulate DCs
to induce co-stimulatory molecules such as B7.1 (CD80) and
B7.2 (CD86) that can enhance a stimulatory activity of DCs
or, alternatively, would help to promote CD4+ T cell activation
and subsequent upregulation of co-stimulatory molecule, such
as CD40L, engagement of which then results in maturation
and stimulation of otherwise immature DCs. As a consequence
of such IL-2 conditioning, the resulting DCs would then
facilitate the robust proliferative responses of bystander CD8+
T cells. In fact, despite some controversial results (44), the
upregulation of CD80 and CD86 on DCs has been documented
in RAG−/− mice (19); here, the expression of these molecules
on DCs was higher in RAG−/− mice than in normal B6 mice,
and was largely attributed to the lack of CD4+ T regulatory
(Treg) cells, which are known to restrain upregulation of co-
stimulatory molecules and maturation/activation of steady-state
DCs via CTLA4 (45–47). More importantly, DC costimulation
was even further upregulated in RAG−/− mice when adoptively
transferred with naïve CD4+ T cells. Although IL-2 has not been
considered as a modulatory factor for DCs in this study, the
enhanced DC expression of co-stimulatory molecules observed
with CD4+ T cell transfer into RAG−/− hosts did not seem to
require the activity of IL-2—presumably produced from CD4+
T cells transferred—on DCs with mainly two reasons: First,
the enhancement of CD80 and CD86 expression on DCs in
RAG−/− mice was not detected with in vivo administration
of IL-2 delivered as a form of IL-2 and anti-IL-2 immune
complexes (19), for which we also confirmed in our study (data
not shown). Second, similar to the results observed with CD4+
T cell transfer into RAG−/− hosts, the enhanced expression
of DC costimulatory molecules has also been reported in mice
lacking IL-2 or its receptors (CD25 and CD122), which is known
to be accompanied by spontaneous activation of conventional
CD4+ CD25− T cells resulting from the lack of Treg suppression
in these mice (48). Hence, although we favor the view that
IL-2 is dispensable for inducing the enhanced DC expression
of co-stimulatory molecules, the additional experiments—e.g.,
using adoptive transfer with CD25- or CD122-deficient OT-I
cells into RAG−/− hosts—will be necessary to provide strong
evidence for a direct stimulatory role of IL-2 on CD8+ T
cells.
Whether these observations with increased levels of IL-2 have
any particular relevance in a normal physiological condition
remains to be addressed. In this respect, it has been shown
that, similar to responses in RAG−/− hosts, naïve CD4+ T
cells also undergo the rapid and intense form of SP response
upon adoptive transfer into neonatal hosts (neonates at 1–3 days
of age) (49). Therefore, it will be of interesting to investigate
whether some, if not all, of the SP response of naïve T cells
(especially for CD8+ T cells) that occur during a neonatal
period is perhaps IL-2-dependent and how these cells would
behave for their homeostasis and function throughout an adult
life. With regard to the functional aspect of IL-2-driven T
cell responses, we showed that these cells after the intense
proliferative responses (both in RAG−/− hosts and in lympho-
depleted B6 hosts with LCMV infections) are able to fully
differentiate into effector and memory cells that are functional
for controlling pathogenic infections at levels equivalent to those
of antigen-induced effector/memory cells (Figure 7). Therefore,
it seems clear that these findings, together with additional
future studies, would provide better understanding of the precise
nature of the strong SP response of polyclonal naïve T cells
in chronic lymphopenic hosts and of previously unappreciated
role of IL-2 in regulating their homeostasis and functional
responses.
In summary, besides a role of enhanced DC costimulation
(19), a clear stimulatory role of IL-2 is apparent for naïve CD8+
T cells in SPF RAG−/− hosts. We show here in this study that
this IL-2-driven stimulatory effect occurs only in a particular
situation where CD4+ T cells co-exist and their strong antigen-
dependent activation is induced under various lymphopenic
environments. Although the phenomenon observed in these
particular conditions seems less physiological, our findings
nevertheless would have an implication for the development
of therapeutic interventions against cancer, especially for those
of using pre-conditioning regime of lymph-depletion prior to
adoptive T cell transfer-based immunotherapy (50–54).
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